Aurinia Pharmaceuticals Inc
AUPH Real Time Price USDRecent trades of AUPH by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by AUPH's directors and management
Government lobbying spending instances
-
$22,500 Apr 30, 2019 Issue: Health Issues
-
$22,500 Jan 11, 2019 Issue: Health Issues
-
$22,500 Oct 30, 2018 Issue: Health Issues
-
$22,500 Jul 25, 2018 Issue: Health Issues
-
$22,500 Apr 20, 2018 Issue: Health Issues
-
$7,500 Jan 12, 2018 Issue: None
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of AUPH in WallStreetBets Daily Discussion
Recent insights relating to AUPH
Recent picks made for AUPH stock on CNBC
ETFs with the largest estimated holdings in AUPH
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AUPH Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.